Clinical Trial Update: Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating focal radiation with pulsed systemic therapy (abiraterone, ADT, and olaparib) for castration-sensitive oligometastatic prostate canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• Androgen deprivation therapy (Androgen deprivation therapy)
• Olaparib (Olaparib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer, Castrate Sensitive Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING